,Set,NGenes,Direction,PValue,FDR
1,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,5.92708675463096e-13,4.88391948581591e-10
2,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,4.12886520068026e-12,1.70109246268027e-09
3,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,1.93980962660888e-09,5.32801044108573e-07
4,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,5.42878243318598e-09,1.11832918123631e-06
5,WP_MEVALONATE_PATHWAY,7,Up,1.35827427898252e-07,2.23843601176319e-05
6,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,43,Down,8.27800694816507e-07,0.000112343929923025
7,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,9.54378045462592e-07,0.000112343929923025
8,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Up,2.59657408177883e-05,0.0026744713042322
9,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,68,Up,5.36048281771608e-05,0.00490781982422005
10,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,7.84909806052707e-05,0.00646765680187431
11,WP_VITAMIN_B12_METABOLISM,24,Down,0.000106700080948415,0.00799280606377215
12,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.000120175794664957,0.0082520712336604
13,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.0002582521808737,0.0153869893993206
14,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.000261429431541856,0.0153869893993206
15,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.000418353568794675,0.0220045323150814
16,WP_CREATINE_PATHWAY,2,Down,0.000427272472137502,0.0220045323150814
17,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Up,0.000491967692692058,0.0238459634575445
18,WP_FOLATE_METABOLISM,37,Down,0.00100480059436832,0.0459975383199721
19,WP_IL18_SIGNALING,192,Down,0.00127847079037262,0.0554452595403704
20,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.00150885936872555,0.0621650059914927
21,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.00167480555293825,0.0657161797914818
22,WP_IRON_METABOLISM_IN_PLACENTA,10,Down,0.00207038493046638,0.077545326486559
23,WP_CHOLESTEROL_METABOLISM,53,Up,0.0021661725652066,0.0776054866839236
24,WP_COMPLEMENT_ACTIVATION,12,Down,0.00291695944159796,0.0896679564411832
25,WP_RANKLRANK_SIGNALING,47,Down,0.00292058754799652,0.0896679564411832
26,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.00302512483418477,0.0896679564411832
27,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.00310082958766072,0.0896679564411832
28,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.00314544665087043,0.0896679564411832
29,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.00315578972911931,0.0896679564411832
30,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.00341441946084355,0.0937827211911695
31,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.00381717216843277,0.101462898928665
32,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,50,Down,0.00414781034265749,0.10680611632343
33,WP_BURN_WOUND_HEALING,62,Down,0.0043817970931262,0.10941214559806
34,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.00458505438308263,0.111120141519414
35,WP_LUNG_PATHOLOGY_OF_COVID19,15,Down,0.00494926433363494,0.116519823169006
36,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.00528392561958427,0.120943186403818
37,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,100,Down,0.00584580467416577,0.126699241883249
38,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,15,Down,0.00591815694715254,0.126699241883249
39,WP_ALLOGRAFT_REJECTION,51,Down,0.00599668741923144,0.126699241883249
40,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.00637676825359857,0.131361426024131
41,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.00736547651356417,0.148028113345777
42,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Up,0.00762534785940562,0.149602062765482
43,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.00793858422769035,0.152125427991089
44,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.0110366222208341,0.206685834317439
45,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Down,0.0130954407344938,0.239792070338287
46,WP_PROSTAGLANDIN_SIGNALING,24,Down,0.013873076934167,0.244517313615647
47,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Down,0.0139469826940964,0.244517313615647
48,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.014285039407523,0.245226509829145
49,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.0149187846155775,0.250879153535426
50,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.0155976586506113,0.25095062509337
51,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.0157083120872819,0.25095062509337
52,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.0158366899330768,0.25095062509337
53,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,67,Down,0.0162590419252035,0.252782085780522
54,WP_KININKALLIKREIN_PATHWAY,2,Up,0.017356972139741,0.264854537836048
55,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.0179807279302833,0.269383996628245
56,WP_NOTCH_SIGNALING_WP268,35,Up,0.0189173170346178,0.278354807795091
57,WP_VITAMIN_D_METABOLISM,6,Up,0.019356921369688,0.279826372081104
58,WP_SMALL_CELL_LUNG_CANCER,71,Down,0.0200431690040283,0.280407588452148
59,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.0213960815530534,0.280407588452148
60,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Up,0.0218623793834077,0.280407588452148
61,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.021908164378952,0.280407588452148
62,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.0219224778492964,0.280407588452148
63,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.0221028659252029,0.280407588452148
64,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.0223437722982356,0.280407588452148
65,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.0223858464134294,0.280407588452148
66,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.0224598311138856,0.280407588452148
67,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.0230122026973685,0.283015746606442
68,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,36,Down,0.0235913672258333,0.285871861677744
69,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.0241824288614153,0.288787266402989
70,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.025312869843136,0.29589410518488
71,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.0254957299370467,0.29589410518488
72,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Down,0.0264860330285584,0.303117933549058
73,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.0272051046739116,0.307082277415111
74,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.0275987451368331,0.30731575665879
75,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,139,Down,0.0281786289024836,0.309589202875287
76,WP_DISORDERS_IN_KETOLYSIS,4,Up,0.028932117343608,0.313685061725434
77,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.0297006706919249,0.317835748703196
78,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0303664386765904,0.320452189566549
79,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.0307229647764046,0.320452189566549
80,WP_MACROPHAGE_MARKERS,8,Down,0.0324902544683463,0.334649621023967
81,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.0339205022006592,0.344148786910525
82,WP_HEART_DEVELOPMENT,17,Up,0.0343814192955161,0.344148786910525
83,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.0346654724679291,0.344148786910525
84,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.0357879596712333,0.347430814034147
85,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.0359896188685845,0.347430814034147
86,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Up,0.036260983018127,0.347430814034147
87,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.0384387799192969,0.364063846591962
88,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,9,Down,0.039343931147563,0.366237976343756
89,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.0395572571536338,0.366237976343756
90,WP_ERBB_SIGNALING,68,Down,0.0404264118655984,0.36771055561839
91,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.0406378502292775,0.36771055561839
92,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.0414798946737351,0.36771055561839
93,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.0415013127093572,0.36771055561839
94,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Up,0.0422864230401736,0.370680984947905
95,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.0436920351470293,0.378970915380549
96,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.0441822810263063,0.379231245475795
97,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0496976043962442,0.422173464149539
98,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Down,0.0506934680772898,0.425207248561006
99,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.0510867932130335,0.425207248561006
100,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.0531456504106182,0.434730590567337
101,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Down,0.0533131606327029,0.434730590567337
102,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.054117024999418,0.434730590567337
103,WP_MALE_INFERTILITY,70,Down,0.0543413238209171,0.434730590567337
104,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.055247808897831,0.436326408132738
105,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.055599845696526,0.436326408132738
106,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.0564352782398407,0.438704427071969
107,WP_OREXIN_RECEPTOR_PATHWAY,118,Down,0.0575083062847101,0.442867704472908
108,WP_TP53_NETWORK,16,Down,0.0600425893434225,0.458102718694261
109,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,79,Down,0.0628993406831881,0.475495933238046
110,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Down,0.0636335114439368,0.476672849361854
111,WP_HISTONE_MODIFICATIONS,37,Down,0.0654936162437023,0.483335134443748
112,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.0667967949590397,0.483335134443748
113,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.0668109921117223,0.483335134443748
114,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.0668691812215864,0.483335134443748
115,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,53,Up,0.0684739994907429,0.490631092003236
116,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Up,0.0700573176707105,0.493008830990992
117,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.0704777425812284,0.493008830990992
118,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.0706007791953119,0.493008830990992
119,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.0727648631557046,0.502333036213265
120,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.0731552965359124,0.502333036213265
121,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,43,Down,0.075384654781864,0.512781265649198
122,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.0759214980694201,0.512781265649198
123,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,7,Up,0.0817188724375772,0.539682657560603
124,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.0819697868134263,0.539682657560603
125,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.0824701801952439,0.539682657560603
126,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.0825242898697038,0.539682657560603
127,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Down,0.085639320292461,0.555605757676583
128,WP_DOPAMINE_METABOLISM,7,Up,0.0876278059080091,0.555605757676583
129,WP_IRON_METABOLISM_DISORDERS,13,Down,0.0882839248700979,0.555605757676583
130,WP_LUNG_FIBROSIS,36,Down,0.0890171607667871,0.555605757676583
131,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.089552462472212,0.555605757676583
132,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.0896184946549666,0.555605757676583
133,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.0896900672086875,0.555605757676583
134,WP_APOPTOSIS,72,Down,0.0904724877192745,0.555605757676583
135,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.0910276423377897,0.555605757676583
136,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.093797767354014,0.563494904059046
137,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.0941778896118315,0.563494904059046
138,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.0943717193691121,0.563494904059046
139,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.0964360482322086,0.57167844419669
140,WP_IL26_SIGNALING,32,Down,0.0974275200391669,0.57343054651624
141,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.100438678434232,0.586960787445443
142,WP_GPCRS_OTHER,15,Down,0.101514603328467,0.589070655934201
143,WP_ONCOSTATIN_M_SIGNALING,56,Down,0.103179853867714,0.594546850258716
144,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.104439324424903,0.597625023098054
145,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.106149188901292,0.603220218308035
146,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.10692189040536,0.603449573246687
147,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.107731934586802,0.60388512992874
148,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.109525238907582,0.609789167971942
149,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.11210384522563,0.619837515472314
150,WP_ATM_SIGNALING,34,Down,0.112948022268231,0.619837515472314
151,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Down,0.11358672917029,0.619837515472314
152,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.116383851929702,0.630922986776807
153,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Down,0.118982959562986,0.63999972476367
154,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.119611599045637,0.63999972476367
155,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.123336145934506,0.655670866129244
156,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.126681796723036,0.669139746793474
157,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.128953317306784,0.676799576183377
158,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.134217029030602,0.694397482287879
159,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.134827075778578,0.694397482287879
160,WP_AXON_GUIDANCE,36,Up,0.134834462580171,0.694397482287879
161,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.13779002046153,0.702562239403967
162,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Up,0.138125100465343,0.702562239403967
163,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.140566741520032,0.70886638204683
164,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.141085056620971,0.70886638204683
165,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Up,0.144362290373816,0.711029086506932
166,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.145697272647865,0.711029086506932
167,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Down,0.14600344741237,0.711029086506932
168,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.146041837337798,0.711029086506932
169,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.147969249524189,0.711029086506932
170,WP_ASPIRIN_AND_MIRNAS,8,Down,0.148827013677126,0.711029086506932
171,WP_GLUCURONIDATION,7,Up,0.149089725240045,0.711029086506932
172,WP_MONOAMINE_TRANSPORT,12,Down,0.149210350688217,0.711029086506932
173,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,18,Up,0.149949428293554,0.711029086506932
174,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.150144491568211,0.711029086506932
175,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.152288070230409,0.716432655492927
176,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.154421860527602,0.716432655492927
177,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.154752862993965,0.716432655492927
178,WP_DNA_REPLICATION,36,Up,0.154763364900171,0.716432655492927
179,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Down,0.156742862998317,0.717533995058964
180,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Down,0.156742862998317,0.717533995058964
181,WP_WNT_SIGNALING_WP428,60,Up,0.158855989380715,0.723189697512205
182,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.160063434732093,0.724682803402442
183,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Down,0.161094953484321,0.725367440825576
184,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.162610738837159,0.728213308705538
185,WP_PEPTIDE_GPCRS,16,Up,0.164550443756997,0.732354107710947
186,WP_SPINAL_CORD_INJURY,69,Down,0.165312941789122,0.732354107710947
187,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Up,0.16806182730968,0.737991449014566
188,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.168376689823712,0.737991449014566
189,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.171976907923505,0.748954661987527
190,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.17269585652625,0.748954661987527
191,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.1740594816032,0.750916297597052
192,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.175824978702341,0.751086859145042
193,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.175922043464798,0.751086859145042
194,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.177041397569619,0.751969647409105
195,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.179524479371031,0.753426023159991
196,WP_MEASLES_VIRUS_INFECTION,101,Down,0.181003769595344,0.753426023159991
197,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.181922436483369,0.753426023159991
198,WP_UROTENSINIIMEDIATED_SIGNALING,49,Down,0.18404841690963,0.753426023159991
199,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.184606484759419,0.753426023159991
200,WP_JOUBERT_SYNDROME,71,Up,0.18475828693445,0.753426023159991
201,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Up,0.185605054559054,0.753426023159991
202,WP_GLUTATHIONE_METABOLISM,10,Up,0.186502790494689,0.753426023159991
203,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.186702541324977,0.753426023159991
204,WP_ENDOCHONDRAL_OSSIFICATION,28,Up,0.189782133183005,0.753426023159991
205,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,28,Up,0.189782133183005,0.753426023159991
206,WP_OSTEOPONTIN_SIGNALING,12,Down,0.190005822251761,0.753426023159991
207,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.191784988671402,0.753426023159991
208,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.191910135669453,0.753426023159991
209,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.192167339521655,0.753426023159991
210,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Up,0.192413408788159,0.753426023159991
211,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Down,0.19292826563927,0.753426023159991
212,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.195282399031202,0.757858773165875
213,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.195972807876054,0.757858773165875
214,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.198303099038516,0.757858773165875
215,WP_WNT_SIGNALING_WP363,39,Up,0.199298836996521,0.757858773165875
216,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.201248166628529,0.757858773165875
217,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.202195483597859,0.757858773165875
218,WP_ENDOTHELIN_PATHWAYS,12,Up,0.204387533215077,0.757858773165875
219,WP_PROLACTIN_SIGNALING,70,Down,0.204635240863445,0.757858773165875
220,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.204941033819733,0.757858773165875
221,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.205026034073329,0.757858773165875
222,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.205567109873562,0.757858773165875
223,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.20576953248011,0.757858773165875
224,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.206019860666451,0.757858773165875
225,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.210411073234896,0.769628075245238
226,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.211472125362132,0.769628075245238
227,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.21202132655421,0.769628075245238
228,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.21634399301867,0.781874781786771
229,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.219270217977022,0.782014430814186
230,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.21950809907135,0.782014430814186
231,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.220651681485402,0.782014430814186
232,WP_TGFB_SMAD_SIGNALING,7,Up,0.221114346739725,0.782014430814186
233,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,9,Down,0.221236660558006,0.782014430814186
234,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.224040711812168,0.782014430814186
235,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.224286917694206,0.782014430814186
236,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.224783088372067,0.782014430814186
237,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.225387594641174,0.782014430814186
238,WP_NUCLEAR_RECEPTORS_METAPATHWAY,180,Down,0.228312951907977,0.782014430814186
239,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.228519019096309,0.782014430814186
240,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.230350121108938,0.782014430814186
241,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.231832143815894,0.782014430814186
242,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.23189931342265,0.782014430814186
243,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Down,0.232170765826445,0.782014430814186
244,WP_VITAMIN_B12_DISORDERS,9,Up,0.232394287092945,0.782014430814186
245,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.232516426637713,0.782014430814186
246,WP_G13_SIGNALING,29,Up,0.234795722976459,0.783937102886209
247,WP_KLEEFSTRA_SYNDROME,25,Down,0.235000587003315,0.783937102886209
248,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.236452034553641,0.783937102886209
249,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.237767620678453,0.783937102886209
250,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Up,0.239947605899215,0.783937102886209
251,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.240542487008581,0.783937102886209
252,WP_SELENIUM_MICRONUTRIENT_NETWORK,51,Down,0.241371497890775,0.783937102886209
253,WP_B_CELL_RECEPTOR_SIGNALING,86,Down,0.241657536429068,0.783937102886209
254,WP_GLYOXYLATE_METABOLISM,5,Up,0.241691482917967,0.783937102886209
255,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.242884473445992,0.783937102886209
256,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.244718621746303,0.783937102886209
257,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.244718621746303,0.783937102886209
258,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,92,Up,0.245631005250304,0.783937102886209
259,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.246407414620786,0.783937102886209
260,WP_FOCAL_ADHESION,122,Up,0.248248828024795,0.784348816014698
261,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.248916520727589,0.784348816014698
262,WP_ZINC_HOMEOSTASIS,25,Up,0.250881758102893,0.784348816014698
263,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,175,Down,0.25173553014196,0.784348816014698
264,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Up,0.25463535601709,0.784348816014698
265,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.256829992483498,0.784348816014698
266,WP_NAD_METABOLISM,12,Down,0.257031547775467,0.784348816014698
267,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Up,0.258666549512015,0.784348816014698
268,WP_SILDENAFIL_TREATMENT,11,Down,0.259759691731338,0.784348816014698
269,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,82,Up,0.261987422958973,0.784348816014698
270,WP_ID_SIGNALING,12,Down,0.262745096662304,0.784348816014698
271,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.264429207151492,0.784348816014698
272,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.267454233162685,0.784348816014698
273,WP_PURINERGIC_SIGNALING,15,Up,0.267754582115649,0.784348816014698
274,WP_NEPHROGENESIS,4,Up,0.26842565481928,0.784348816014698
275,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Up,0.268979654921019,0.784348816014698
276,WP_DNA_DAMAGE_RESPONSE,59,Down,0.270617122767182,0.784348816014698
277,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.271216992548532,0.784348816014698
278,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.273448316044303,0.784348816014698
279,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.273560368566903,0.784348816014698
280,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.273642504834437,0.784348816014698
281,WP_BENZENE_METABOLISM,3,Up,0.274356976684413,0.784348816014698
282,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.274951200611855,0.784348816014698
283,WP_NEURAL_CREST_DIFFERENTIATION,40,Up,0.275455161484173,0.784348816014698
284,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.276169408613644,0.784348816014698
285,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.276227392308635,0.784348816014698
286,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.27649913325227,0.784348816014698
287,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.27751726419962,0.784348816014698
288,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,63,Down,0.277522675595284,0.784348816014698
289,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.277902947696633,0.784348816014698
290,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.278651540900023,0.784348816014698
291,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.279537539790064,0.784348816014698
292,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.279973598401427,0.784348816014698
293,WP_RETINOL_METABOLISM,6,Up,0.280242274873143,0.784348816014698
294,WP_ACE_INHIBITOR_PATHWAY,5,Up,0.280533980984867,0.784348816014698
295,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.281512974833269,0.784348816014698
296,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.282573302560945,0.784348816014698
297,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.282729262890967,0.784348816014698
298,WP_GPR40_PATHWAY,8,Down,0.284401407764276,0.784348816014698
299,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.287025734304292,0.784348816014698
300,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.28794807983274,0.784348816014698
301,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.289009078951023,0.784348816014698
302,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,57,Up,0.291076764659292,0.784348816014698
303,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,277,Up,0.291753958549216,0.784348816014698
304,WP_MELANOMA,55,Down,0.292527060032754,0.784348816014698
305,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.292794047013111,0.784348816014698
306,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.293767647082109,0.784348816014698
307,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.295462274226152,0.784348816014698
308,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Down,0.29733007840289,0.784348816014698
309,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.29816645387963,0.784348816014698
310,WP_AMINO_ACID_METABOLISM,60,Up,0.298475059740877,0.784348816014698
311,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.298495212175579,0.784348816014698
312,WP_FERROPTOSIS,52,Down,0.298509803195084,0.784348816014698
313,WP_16P112_DISTAL_DELETION_SYNDROME,21,Down,0.299401491724764,0.784348816014698
314,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.300090446857673,0.784348816014698
315,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,88,Down,0.300282090940359,0.784348816014698
316,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.300793963423112,0.784348816014698
317,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.30235939242021,0.784683784522069
318,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.304821065067672,0.784683784522069
319,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Up,0.305953334280272,0.784683784522069
320,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Up,0.306234684682464,0.784683784522069
321,WP_NPHP1_DELETION_SYNDROME,10,Up,0.306390185037919,0.784683784522069
322,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.306636139097216,0.784683784522069
323,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,63,Up,0.313130615548961,0.794436533887768
324,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.313745496272209,0.794436533887768
325,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.314027530545592,0.794436533887768
326,WP_TNFALPHA_SIGNALING,83,Down,0.314941192844113,0.794436533887768
327,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.31526789633653,0.794436533887768
328,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.320927896730414,0.803357997428066
329,WP_IL9_SIGNALING,15,Down,0.321081172130358,0.803357997428066
330,WP_NUCLEAR_RECEPTORS,20,Down,0.321733178581628,0.803357997428066
331,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.325985107952002,0.8098199385053
332,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.326286674252136,0.8098199385053
333,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.329755796965711,0.812984425170962
334,WP_NETRINUNC5B_SIGNALING,35,Down,0.333325735736287,0.812984425170962
335,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.334080559765099,0.812984425170962
336,WP_ARYLAMINE_METABOLISM,1,Up,0.334898139244718,0.812984425170962
337,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Up,0.335177635303593,0.812984425170962
338,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Down,0.33528187456181,0.812984425170962
339,WP_IDO_METABOLIC_PATHWAY,8,Down,0.336058633584981,0.812984425170962
340,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.33679507279247,0.812984425170962
341,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.337166652326668,0.812984425170962
342,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.337428001709307,0.812984425170962
343,WP_SPINA_BIFIDA,10,Down,0.338790791912454,0.813888083194934
344,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.340398249144811,0.814924819873985
345,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.341989993278006,0.814924819873985
346,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Down,0.342189305432523,0.814924819873985
347,WP_PANCREATIC_CANCER_SUBTYPES,6,Down,0.345756341805419,0.81514632799965
348,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Up,0.347490245649266,0.81514632799965
349,WP_CELL_CYCLE,95,Up,0.347685119275296,0.81514632799965
350,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.349402493727036,0.81514632799965
351,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.35105430161171,0.81514632799965
352,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Up,0.351302865368479,0.81514632799965
353,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.351503894499888,0.81514632799965
354,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.352146035204104,0.81514632799965
355,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Up,0.354547932083182,0.81514632799965
356,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.355299819096976,0.81514632799965
357,WP_ENDODERM_DIFFERENTIATION,82,Down,0.355742675949529,0.81514632799965
358,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,28,Down,0.356374064636861,0.81514632799965
359,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.356548003880509,0.81514632799965
360,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.357401052689916,0.81514632799965
361,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.357835131681978,0.81514632799965
362,WP_MRNA_PROCESSING,124,Down,0.358110401378487,0.81514632799965
363,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,40,Down,0.363518782182003,0.820349678283382
364,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.363659340486968,0.820349678283382
365,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.363676072483389,0.820349678283382
366,WP_INTEGRATED_CANCER_PATHWAY,40,Down,0.365349775489603,0.820349678283382
367,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.365374189235438,0.820349678283382
368,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.372573209589346,0.832955282686062
369,WP_CHOLESTASIS,9,Up,0.374448257839349,0.832955282686062
370,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,14,Up,0.374979883999215,0.832955282686062
371,WP_BLADDER_CANCER,30,Down,0.376265729810349,0.832955282686062
372,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.377581467090431,0.832955282686062
373,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.378006560722817,0.832955282686062
374,WP_CIRCADIAN_RHYTHM_GENES,121,Down,0.378568347896395,0.832955282686062
375,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.379075523067079,0.832955282686062
376,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,73,Down,0.383131834633981,0.834274045838789
377,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.383706246958252,0.834274045838789
378,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.384378298797194,0.834274045838789
379,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.384507977050094,0.834274045838789
380,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.384738030847985,0.834274045838789
381,WP_PPARALPHA_PATHWAY,15,Down,0.38586989509998,0.834532266567936
382,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.391926792388458,0.838394435875036
383,WP_PREIMPLANTATION_EMBRYO,21,Down,0.392168433135437,0.838394435875036
384,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.393268311914567,0.838394435875036
385,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.393468386945064,0.838394435875036
386,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.393705132408492,0.838394435875036
387,WP_TAMOXIFEN_METABOLISM,2,Down,0.393760493548105,0.838394435875036
388,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Down,0.397628801141858,0.844448794177555
389,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.399774942564707,0.846824042862002
390,WP_IL17_SIGNALING,25,Down,0.40145316512085,0.848198482204053
391,WP_TCELL_ACTIVATION_SARSCOV2,61,Down,0.404399952164478,0.852239285379871
392,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.405460834408761,0.852295223349028
393,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.407638110186614,0.854276702137746
394,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.408476966798874,0.854276702137746
395,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.411839480077703,0.856958918141484
396,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.411839480077703,0.856958918141484
397,WP_PLEURAL_MESOTHELIOMA,258,Down,0.413442969741622,0.858128481277322
398,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.415398882580803,0.859892122919856
399,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.417418902350278,0.859892122919856
400,WP_IL2_SIGNALING,37,Down,0.417423360640707,0.859892122919856
401,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.420070575291361,0.860545774998071
402,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.421821447700519,0.860545774998071
403,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,36,Up,0.424012100642515,0.860545774998071
404,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.424405598867775,0.860545774998071
405,WP_IL4_SIGNALING,50,Down,0.42487642566316,0.860545774998071
406,WP_PPAR_SIGNALING,39,Down,0.425035959078605,0.860545774998071
407,WP_COPPER_HOMEOSTASIS,41,Up,0.425324649555757,0.860545774998071
408,WP_HYPERTROPHY_MODEL,13,Down,0.426451274047579,0.860545774998071
409,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.427139832492974,0.860545774998071
410,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.430875609938072,0.86529527529172
411,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.434697850251422,0.86529527529172
412,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.435867986632092,0.86529527529172
413,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.436684777300871,0.86529527529172
414,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.438546591254777,0.86529527529172
415,WP_IL6_SIGNALING,39,Down,0.438950269831281,0.86529527529172
416,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.439926504816437,0.86529527529172
417,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Down,0.440121861175218,0.86529527529172
418,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.442695987952129,0.86529527529172
419,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.443556259964911,0.86529527529172
420,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.445212363546052,0.86529527529172
421,WP_PROTEASOME_DEGRADATION,57,Down,0.44550305731744,0.86529527529172
422,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.446381098792705,0.86529527529172
423,WP_EBOLA_VIRUS_INFECTION_IN_HOST,109,Down,0.449057028364022,0.86529527529172
424,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.449186463093031,0.86529527529172
425,WP_AUTOPHAGY,27,Down,0.449869512850028,0.86529527529172
426,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.450066942971164,0.86529527529172
427,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.450191034315785,0.86529527529172
428,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,19,Down,0.450721195636311,0.86529527529172
429,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.450854524795651,0.86529527529172
430,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Down,0.451646885330911,0.86529527529172
431,WP_MATRIX_METALLOPROTEINASES,10,Down,0.452599834527587,0.86529527529172
432,WP_G_PROTEIN_SIGNALING,62,Up,0.455601342247544,0.869017375027724
433,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.457758001771278,0.86922759441841
434,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.458502468095367,0.86922759441841
435,WP_TRANSLATION_FACTORS,48,Down,0.458876217927194,0.86922759441841
436,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.462936708310756,0.874907907449686
437,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.464234062723633,0.875352099964012
438,WP_SLEEP_REGULATION,11,Down,0.46998792035449,0.882370037251047
439,WP_ADIPOGENESIS,86,Down,0.470097629069429,0.882370037251047
440,WP_OXIDATION_BY_CYTOCHROME_P450,15,Up,0.473888442832298,0.88628867193488
441,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.474336534372915,0.88628867193488
442,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.476486987386367,0.888292483272322
443,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.479891216198952,0.889842337023815
444,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,85,Down,0.479983894307208,0.889842337023815
445,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.480558058222813,0.889842337023815
446,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.482824315696865,0.892034161735913
447,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.487799131970499,0.892838438288924
448,WP_HIPPOYAP_SIGNALING,16,Up,0.487876592105415,0.892838438288924
449,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.490667266094978,0.892838438288924
450,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.491145425715522,0.892838438288924
451,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Up,0.491234618877784,0.892838438288924
452,WP_NOTCH_SIGNALING_WP61,49,Up,0.492399889347989,0.892838438288924
453,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.496569474328089,0.892838438288924
454,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.496806628423669,0.892838438288924
455,WP_INTEGRINMEDIATED_CELL_ADHESION,74,Up,0.497186093350346,0.892838438288924
456,WP_TRYPTOPHAN_METABOLISM,19,Down,0.497482771576991,0.892838438288924
457,WP_HEDGEHOG_SIGNALING_WP4249,24,Up,0.497887437301022,0.892838438288924
458,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.4989091783132,0.892838438288924
459,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.501965131511283,0.892838438288924
460,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.502877826576094,0.892838438288924
461,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.504052697829032,0.892838438288924
462,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.504891120803961,0.892838438288924
463,WP_ANGIOGENESIS,15,Down,0.505180923867454,0.892838438288924
464,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.50532013788208,0.892838438288924
465,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.505659281124067,0.892838438288924
466,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Down,0.505823586990311,0.892838438288924
467,WP_PI3KAKT_SIGNALING,181,Down,0.50601401781666,0.892838438288924
468,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.51210921854905,0.900964874541292
469,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.512885883711048,0.900964874541292
470,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.513899867760203,0.900964874541292
471,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.516034511169535,0.902786490878337
472,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.518365105680694,0.904942472629008
473,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,26,Down,0.523921131246979,0.91123551384023
474,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.524982601898681,0.91123551384023
475,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.525287462468579,0.91123551384023
476,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.528979339307083,0.914599098166465
477,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.530189930361141,0.914599098166465
478,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.532390958049922,0.914599098166465
479,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.532950622112443,0.914599098166465
480,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Down,0.534627314384005,0.914599098166465
481,WP_IL19_SIGNALING,20,Up,0.534860777414605,0.914599098166465
482,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.534996074412908,0.914599098166465
483,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.538399749909458,0.915653041409515
484,WP_ONECARBON_METABOLISM,22,Down,0.538605813769846,0.915653041409515
485,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.539737479190024,0.915653041409515
486,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.546120413431699,0.915653041409515
487,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.547792792547667,0.915653041409515
488,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.548983563956764,0.915653041409515
489,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.54986010244751,0.915653041409515
490,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.550388326016615,0.915653041409515
491,WP_METHYLATION_PATHWAYS,5,Up,0.553098104847559,0.915653041409515
492,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Down,0.554390809763509,0.915653041409515
493,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.556911482390588,0.915653041409515
494,WP_ATR_SIGNALING,10,Down,0.556912444302566,0.915653041409515
495,WP_DNA_MISMATCH_REPAIR,21,Up,0.557994769146195,0.915653041409515
496,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.558811349485263,0.915653041409515
497,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Down,0.558869522300133,0.915653041409515
498,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.558961627252681,0.915653041409515
499,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Down,0.559712474962665,0.915653041409515
500,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Up,0.559957267601067,0.915653041409515
501,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.560146042455884,0.915653041409515
502,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.562043387269115,0.915653041409515
503,WP_IL1_SIGNALING,53,Down,0.562236938939129,0.915653041409515
504,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.562900863242248,0.915653041409515
505,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Down,0.566741224009122,0.915653041409515
506,WP_MAPK_CASCADE,30,Down,0.568810285280917,0.915653041409515
507,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.57057717390678,0.915653041409515
508,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.571644106436754,0.915653041409515
509,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.572085498844105,0.915653041409515
510,WP_VALPROIC_ACID_PATHWAY,9,Up,0.57368463966861,0.915653041409515
511,WP_INSULIN_SIGNALING,131,Down,0.573698154342543,0.915653041409515
512,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.573977227584381,0.915653041409515
513,WP_COMPLEMENT_SYSTEM,53,Down,0.574009729733312,0.915653041409515
514,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.574788704096032,0.915653041409515
515,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Up,0.575935706537513,0.915653041409515
516,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Down,0.576409426459489,0.915653041409515
517,WP_IL11_SIGNALING,40,Down,0.576661638927957,0.915653041409515
518,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.577787623920402,0.915653041409515
519,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,50,Down,0.577885633660415,0.915653041409515
520,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.577890901270938,0.915653041409515
521,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.578950527396065,0.915653041409515
522,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.583069767720327,0.920401319160057
523,WP_FOXP3_IN_COVID19,9,Down,0.587735846235834,0.925992996746323
524,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.590124478591357,0.927982004502439
525,WP_PURINE_METABOLISM,10,Down,0.595906935388594,0.928246364050838
526,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Down,0.596820725030226,0.928246364050838
527,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.597038793556413,0.928246364050838
528,WP_ENDOMETRIAL_CANCER,49,Down,0.597434920477936,0.928246364050838
529,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.598410124716775,0.928246364050838
530,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.599306178015314,0.928246364050838
531,WP_ESTROGEN_METABOLISM_WP5276,8,Down,0.599408914843739,0.928246364050838
532,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.600412307143724,0.928246364050838
533,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,23,Down,0.600663994273236,0.928246364050838
534,WP_GASTRIN_SIGNALING,93,Up,0.602623619601272,0.928246364050838
535,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.602684229086406,0.928246364050838
536,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.603851049919428,0.92830833047315
537,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.605054934545792,0.928426938669892
538,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.608064483429722,0.931310658635856
539,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.610217046821464,0.931840462400457
540,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.611216936952125,0.931840462400457
541,WP_CELLULAR_PROTEOSTASIS,6,Up,0.612552489465194,0.931840462400457
542,WP_HEPATITIS_B_INFECTION,118,Down,0.612933896384767,0.931840462400457
543,WP_KREBS_CYCLE_DISORDERS,11,Up,0.616819499235586,0.933098326148242
544,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Down,0.617967903810258,0.933098326148242
545,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.618472401104635,0.933098326148242
546,WP_CILIOPATHIES,128,Up,0.618924610148817,0.933098326148242
547,WP_ALZHEIMERS_DISEASE,184,Up,0.62223654694366,0.933098326148242
548,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Up,0.62223654694366,0.933098326148242
549,WP_IRINOTECAN_PATHWAY,5,Down,0.622607381243096,0.933098326148242
550,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.622820484686327,0.933098326148242
551,WP_BDNFTRKB_SIGNALING,26,Down,0.624927456390368,0.934555760554743
552,WP_REGULATION_OF_ACTIN_CYTOSKELETON,93,Up,0.628559989703002,0.936127654052399
553,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Up,0.628758376638786,0.936127654052399
554,WP_NEOVASCULARIZATION_PROCESSES,23,Down,0.63180383713381,0.936127654052399
555,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.632144486272676,0.936127654052399
556,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.633547665188381,0.936127654052399
557,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,168,Down,0.633606780138301,0.936127654052399
558,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,24,Down,0.634534949698806,0.936127654052399
559,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.635067182785547,0.936127654052399
560,WP_IL5_SIGNALING,37,Down,0.636959124904536,0.937239855216674
561,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.64089623432967,0.938821084724122
562,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.641045783278006,0.938821084724122
563,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.641579660462404,0.938821084724122
564,WP_STEROID_BIOSYNTHESIS,2,Down,0.642591130806316,0.938821084724122
565,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.648351783995727,0.941951275806545
566,WP_OSTEOCLAST_SIGNALING,9,Down,0.649009802706421,0.941951275806545
567,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.649305797677132,0.941951275806545
568,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.649306219245288,0.941951275806545
569,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.653047097588722,0.945713195805109
570,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.655939053356082,0.947092095228837
571,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.657222298400842,0.947092095228837
572,WP_CYTOSINE_METHYLATION,7,Up,0.660200733562465,0.947092095228837
573,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.662000110957626,0.947092095228837
574,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.66240156142555,0.947092095228837
575,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.665380529576954,0.947092095228837
576,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.665680922708936,0.947092095228837
577,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Up,0.665859428647486,0.947092095228837
578,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,26,Down,0.666705287952536,0.947092095228837
579,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.667171743436995,0.947092095228837
580,WP_SEROTONIN_AND_ANXIETY,7,Down,0.670384681734504,0.947092095228837
581,WP_GPCRS_CLASS_A_RHODOPSINLIKE,46,Down,0.670677244547047,0.947092095228837
582,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.671118562762767,0.947092095228837
583,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Down,0.6713905170037,0.947092095228837
584,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.671572164012717,0.947092095228837
585,WP_ECTODERM_DIFFERENTIATION,78,Up,0.672389412268046,0.947092095228837
586,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.676794017919564,0.949958917684198
587,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.6804688645349,0.949958917684198
588,WP_CAMKK2_PATHWAY,30,Up,0.680533814820464,0.949958917684198
589,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.681231639159789,0.949958917684198
590,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.681782107443719,0.949958917684198
591,WP_LEPTIN_SIGNALING,69,Down,0.681870148496921,0.949958917684198
592,WP_CHEMOKINE_SIGNALING,115,Down,0.686494674253276,0.949958917684198
593,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,71,Up,0.686788966501864,0.949958917684198
594,WP_CILIARY_LANDSCAPE,185,Up,0.68817397113319,0.949958917684198
595,WP_NEUROINFLAMMATION,10,Down,0.688390181649924,0.949958917684198
596,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.68853821561368,0.949958917684198
597,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Up,0.690744739899124,0.949958917684198
598,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Down,0.69158789225544,0.949958917684198
599,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.692461375213409,0.949958917684198
600,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.693949103086236,0.949958917684198
601,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.694293855858368,0.949958917684198
602,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Down,0.696338841255412,0.949958917684198
603,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.69696027703231,0.949958917684198
604,WP_TCA_CYCLE_IN_SENESCENCE,10,Down,0.69703394484803,0.949958917684198
605,WP_CCL18_SIGNALING,22,Down,0.698039726180559,0.949958917684198
606,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.69863483509299,0.949958917684198
607,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.699900966976457,0.950112680047118
608,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.70156810720325,0.95080940844651
609,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.705024349784465,0.952771755651213
610,WP_BENZOAPYRENE_METABOLISM,5,Down,0.705328605518495,0.952771755651213
611,WP_TRANSSULFURATION_PATHWAY,8,Down,0.70678053595259,0.953170477291218
612,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.710142460998364,0.956139522651392
613,WP_PYRIMIDINE_METABOLISM,71,Up,0.715638294313099,0.9619672993703
614,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.7176683563323,0.962584521491383
615,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.718433835821845,0.962584521491383
616,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.724153605491506,0.963314859475584
617,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.724449941184129,0.963314859475584
618,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.729620632222892,0.963314859475584
619,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.731012403593553,0.963314859475584
620,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.732616466939276,0.963314859475584
621,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Down,0.732894920886294,0.963314859475584
622,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.733313155382524,0.963314859475584
623,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,4,Down,0.733845046327621,0.963314859475584
624,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.734421751977797,0.963314859475584
625,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Up,0.734835278985156,0.963314859475584
626,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Up,0.737023100777766,0.963314859475584
627,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.738690614660592,0.963314859475584
628,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.739355766709308,0.963314859475584
629,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.739580607486337,0.963314859475584
630,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.740237937282562,0.963314859475584
631,WP_NRF2ARE_REGULATION,21,Up,0.744816308661045,0.963314859475584
632,WP_HUNGER_AND_SATIETY,2,Down,0.746086523520605,0.963314859475584
633,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.747105789592841,0.963314859475584
634,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Down,0.747502718440468,0.963314859475584
635,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,55,Up,0.747908518538903,0.963314859475584
636,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.747914543473411,0.963314859475584
637,WP_SYNAPTIC_VESICLE_PATHWAY,22,Down,0.748202076602619,0.963314859475584
638,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.74827771340641,0.963314859475584
639,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,23,Down,0.748593692480035,0.963314859475584
640,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.749347712106665,0.963314859475584
641,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.751279698945056,0.963314859475584
642,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.751437976390188,0.963314859475584
643,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.752875182140744,0.963314859475584
644,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.755620688579351,0.963314859475584
645,WP_BARDETBIEDL_SYNDROME,65,Up,0.756809131656404,0.963314859475584
646,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.757430787765205,0.963314859475584
647,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.758253355258165,0.963314859475584
648,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.759170187637716,0.963314859475584
649,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.759560278503477,0.963314859475584
650,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.759896430411565,0.963314859475584
651,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.768075005522484,0.968663714383726
652,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.76862160283318,0.968663714383726
653,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.770083868645598,0.968663714383726
654,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.770302062379074,0.968663714383726
655,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.771694065734715,0.968663714383726
656,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.772732549188232,0.968663714383726
657,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Down,0.774819095979687,0.968663714383726
658,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.775659016685185,0.968663714383726
659,WP_FRAGILE_X_SYNDROME,84,Up,0.775929473659866,0.968663714383726
660,WP_DRAVET_SYNDROME,14,Up,0.77645543902507,0.968663714383726
661,WP_ALSTROM_SYNDROME,27,Up,0.777312370313511,0.968663714383726
662,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.778326373271709,0.968663714383726
663,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.780931460128597,0.968663714383726
664,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.781514515727857,0.968663714383726
665,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.787049414565448,0.968663714383726
666,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.788039892596697,0.968663714383726
667,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.788969135094451,0.968663714383726
668,WP_BASE_EXCISION_REPAIR,29,Up,0.78904097195727,0.968663714383726
669,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.789523167820319,0.968663714383726
670,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.789674065901944,0.968663714383726
671,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Up,0.791601008585563,0.968663714383726
672,WP_MTHFR_DEFICIENCY,18,Down,0.79216746137939,0.968663714383726
673,WP_SERINE_METABOLISM,5,Down,0.792586576997415,0.968663714383726
674,WP_NEPHROTIC_SYNDROME,27,Up,0.792742276867985,0.968663714383726
675,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.794824266888561,0.968663714383726
676,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.795773297337932,0.968663714383726
677,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Up,0.796645500831618,0.968663714383726
678,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.797549575566687,0.968663714383726
679,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.798484608017186,0.968663714383726
680,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.803844427427357,0.968663714383726
681,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Up,0.804039456544479,0.968663714383726
682,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.804741552012746,0.968663714383726
683,WP_AEROBIC_GLYCOLYSIS,10,Up,0.8049773399246,0.968663714383726
684,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.8049773399246,0.968663714383726
685,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.805994615519662,0.968663714383726
686,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,41,Down,0.806436053479655,0.968663714383726
687,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.808190187142083,0.968709406877319
688,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Up,0.808897286830004,0.968709406877319
689,WP_TAR_SYNDROME,44,Down,0.810000948226302,0.968709406877319
690,WP_SPHINGOLIPID_PATHWAY,21,Up,0.814853629226616,0.973100565917003
691,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.816238875808733,0.973344187650356
692,WP_SMALL_LIGAND_GPCRS,7,Up,0.818134959324805,0.973910994447902
693,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Down,0.819543355085234,0.973910994447902
694,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.820259988042287,0.973910994447902
695,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.823712839530956,0.975561606832039
696,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.824619313635934,0.975561606832039
697,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.825481338918632,0.975561606832039
698,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.826828270221144,0.975561606832039
699,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.827740501282591,0.975561606832039
700,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.828753792211684,0.975561606832039
701,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,13,Down,0.835449704514616,0.979469467830459
702,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.836506141919334,0.979469467830459
703,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.836585933989857,0.979469467830459
704,WP_PDGF_PATHWAY,36,Down,0.837708923906995,0.979469467830459
705,WP_RAS_SIGNALING,119,Up,0.838131838260978,0.979469467830459
706,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.839205636272214,0.979469467830459
707,WP_ENERGY_METABOLISM,41,Up,0.846377900813856,0.982136452212254
708,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.84676514806784,0.982136452212254
709,WP_IL7_SIGNALING,23,Up,0.848513867974563,0.982136452212254
710,WP_NUCLEOTIDE_GPCRS,6,Up,0.849878625445921,0.982136452212254
711,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.851337398392739,0.982136452212254
712,WP_RAC1PAK1P38MMP2_PATHWAY,52,Up,0.851948556703993,0.982136452212254
713,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Up,0.852550879139495,0.982136452212254
714,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.853622803146475,0.982136452212254
715,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.855045534294301,0.982136452212254
716,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.856150763460947,0.982136452212254
717,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.856571582147818,0.982136452212254
718,WP_PRIMARY_OVARIAN_INSUFFICIENCY,89,Down,0.857524437999721,0.982136452212254
719,WP_VITAMIN_D_RECEPTOR_PATHWAY,87,Down,0.860171669653664,0.982136452212254
720,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.861495368935764,0.982136452212254
721,WP_IL3_SIGNALING,46,Up,0.862493814005537,0.982136452212254
722,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.86262152482315,0.982136452212254
723,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Down,0.864281002483015,0.982136452212254
724,WP_P38_MAPK_SIGNALING,31,Down,0.866230544051295,0.982136452212254
725,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.866797067105149,0.982136452212254
726,WP_HEME_BIOSYNTHESIS,8,Up,0.866797067105149,0.982136452212254
727,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Up,0.867703401183498,0.982136452212254
728,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.867712787876845,0.982136452212254
729,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.869744127757467,0.983085269234778
730,WP_CORI_CYCLE,11,Up,0.875031791181561,0.985836500226185
731,WP_ACUTE_VIRAL_MYOCARDITIS,66,Up,0.876149091626734,0.985836500226185
732,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.87730943475675,0.985836500226185
733,WP_OPIOID_RECEPTOR_PATHWAYS,26,Down,0.881350595180151,0.985836500226185
734,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Down,0.881821426984584,0.985836500226185
735,WP_MONOAMINE_GPCRS,4,Up,0.883457958867794,0.985836500226185
736,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.884546496110933,0.985836500226185
737,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.884781466669576,0.985836500226185
738,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.885357509779701,0.985836500226185
739,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.885618378121643,0.985836500226185
740,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.885729778627263,0.985836500226185
741,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.887113897463657,0.985836500226185
742,WP_RETT_SYNDROME,32,Up,0.888805981237188,0.985836500226185
743,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.888927815131135,0.985836500226185
744,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.890916779842751,0.986714283051648
745,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.892517647911423,0.987160458898004
746,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.895578338282463,0.988125979000582
747,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.895866555207642,0.988125979000582
748,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.897737904474365,0.988125979000582
749,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Down,0.899938712912945,0.988125979000582
750,WP_NRXN1_DELETION_SYNDROME,2,Down,0.900294426258744,0.988125979000582
751,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Up,0.900585692026016,0.988125979000582
752,WP_EGFEGFR_SIGNALING,140,Down,0.906094314810646,0.99027225222848
753,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.907309124969246,0.99027225222848
754,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.907553509363451,0.99027225222848
755,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.908199605890461,0.99027225222848
756,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Up,0.908791657972027,0.99027225222848
757,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.910966097912464,0.99027225222848
758,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Down,0.911959960894169,0.99027225222848
759,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.912156115826961,0.99027225222848
760,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Down,0.913936383333438,0.990278568360491
761,WP_CANCER_PATHWAYS,309,Down,0.91456552247856,0.990278568360491
762,WP_THERMOGENESIS,74,Up,0.918284552729938,0.991622226781975
763,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.918956326842082,0.991622226781975
764,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Up,0.919926139144998,0.991622226781975
765,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.922319936714236,0.991622226781975
766,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.922334599683161,0.991622226781975
767,WP_MIRNA_BIOGENESIS,6,Up,0.923026999929338,0.991622226781975
768,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.927202663621348,0.991636853522242
769,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.927494104904543,0.991636853522242
770,WP_NRF2_PATHWAY,73,Down,0.929410937135889,0.991636853522242
771,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Down,0.929548572735454,0.991636853522242
772,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.930090359575864,0.991636853522242
773,WP_RETINOBLASTOMA_GENE_IN_CANCER,72,Down,0.930694984734172,0.991636853522242
774,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.93172645114989,0.991636853522242
775,WP_VEGFAVEGFR2_SIGNALING,343,Down,0.934685907356204,0.991636853522242
776,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.935302760085927,0.991636853522242
777,WP_KALLMANN_SYNDROME,11,Up,0.935843436671471,0.991636853522242
778,WP_ESTROGEN_SIGNALING,21,Up,0.936278485485806,0.991636853522242
779,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.938391508756763,0.992241319514384
780,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,128,Up,0.939482106122768,0.992241319514384
781,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Up,0.943532798519659,0.992241319514384
782,WP_AGERAGE_PATHWAY,55,Up,0.943619483058854,0.992241319514384
783,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Up,0.946046171909172,0.992241319514384
784,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.94684701668569,0.992241319514384
785,WP_OVARIAN_INFERTILITY,21,Down,0.946961486390256,0.992241319514384
786,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.949851644361479,0.992241319514384
787,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.950858996228894,0.992241319514384
788,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.95094306030253,0.992241319514384
789,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.95094306030253,0.992241319514384
790,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Down,0.951602910375099,0.992241319514384
791,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.952503499679464,0.992241319514384
792,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.956631881228039,0.992641565409429
793,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,33,Down,0.957163812065167,0.992641565409429
794,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.957180842750875,0.992641565409429
795,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.959560511792429,0.992641565409429
796,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.95986309749437,0.992641565409429
797,WP_OSTEOBLAST_SIGNALING,3,Down,0.961675291953663,0.992641565409429
798,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,64,Down,0.961931041208055,0.992641565409429
799,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.96274375295954,0.992641565409429
800,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Up,0.964710223693638,0.992641565409429
801,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Up,0.964934337248729,0.992641565409429
802,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Up,0.97062943842934,0.994719760797971
803,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.971237052775864,0.994719760797971
804,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.971609349058889,0.994719760797971
805,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.972544088989398,0.994719760797971
806,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.972990445634909,0.994719760797971
807,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.976603172563577,0.995573835648938
808,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.976720681977767,0.995573835648938
809,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.977760507489792,0.995573835648938
810,WP_EICOSANOID_SYNTHESIS,14,Down,0.979315950648813,0.995573835648938
811,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.979866966882632,0.995573835648938
812,WP_BREAST_CANCER_PATHWAY,88,Up,0.986268323919332,0.99756951058286
813,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.986311013514603,0.99756951058286
814,WP_FOXA2_PATHWAY,9,Down,0.987442106829112,0.99756951058286
815,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.987828253976055,0.99756951058286
816,WP_PDGFRBETA_PATHWAY,27,Up,0.990219514117262,0.99756951058286
817,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.990591084274062,0.99756951058286
818,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.99116908255969,0.99756951058286
819,WP_HIPPO_SIGNALING_REGULATION,45,Down,0.993313925891309,0.99756951058286
820,WP_MAPK_SIGNALING,164,Down,0.993880594368098,0.99756951058286
821,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Up,0.99442014569062,0.99756951058286
822,WP_PRION_DISEASE_PATHWAY,28,Down,0.995148225362998,0.99756951058286
823,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.997450116032619,0.998662084581869
824,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.999725738755485,0.999725738755485
